Mallappa Rashmi H, Rokana Namita, Duary Raj Kumar, Panwar Harsh, Batish Virender Kumar, Grover Sunita
Molecular Biology Unit, Department of Dairy Microbiology, National Dairy Research Institute, Karnal, Haryana, India.
Indian J Endocrinol Metab. 2012 Jan;16(1):20-7. doi: 10.4103/2230-8210.91178.
Metabolic syndrome is a complex disorder caused by a cluster of interrelated factors that increases the risk of cardiovascular diseases and type 2 diabetes. Obesity is the main precursor for metabolic syndrome that can be targeted in developing various therapies. With this view, several physical, psychological, pharmaceutical and dietary therapies have been proposed for the management of obesity. However, dietary strategies found more appropriate without any adverse health effects. Application of probiotics and prebiotics as biotherapeutics is the new emerging area in developing dietary strategies and many people are interested in learning the facts behind these health claims. Recent studies established the role of probiotics and prebiotics in weight management with possible mechanisms of improved microbial balance, decreased food intake, decreased abdominal adiposity and increased mucosal integrity with decreased inflammatory tone. Hence, the above "Pharmaco-nutritional" approach has been selected and extensively reviewed to gain thorough knowledge on putative mechanisms of probiotic and prebiotic action in order to develop dietary strategies for the management of metabolic syndrome.
代谢综合征是一种由一系列相互关联的因素引起的复杂病症,会增加心血管疾病和2型糖尿病的风险。肥胖是代谢综合征的主要先兆,在开发各种治疗方法时可将其作为靶点。基于这一观点,已经提出了几种物理、心理、药物和饮食疗法来管理肥胖。然而,饮食策略被认为更合适且没有任何不良健康影响。将益生菌和益生元作为生物疗法应用是制定饮食策略的新兴领域,许多人有兴趣了解这些健康宣称背后的事实。最近的研究确立了益生菌和益生元在体重管理中的作用,其可能的机制包括改善微生物平衡、减少食物摄入量、减少腹部肥胖以及增强黏膜完整性并降低炎症反应。因此,选择并广泛回顾了上述“药物营养”方法,以深入了解益生菌和益生元作用的假定机制,从而制定出管理代谢综合征的饮食策略。